静脉注射钆对比剂增强MRI评估脑小血管病中的类淋巴-脑膜淋巴系统
观察性研究纳入20例高负荷脑小血管病(CSVD)患者和15例对照,在静脉注射对比剂前后多时间点行3D T1加权和3D Cube T2-FLAIR成像,测量代表类淋巴和脑膜淋巴管的四个感兴趣区信号强度比(SIR)。CSVD患者24小时清除率(CR24h)更低、SIR变化(∆SIR)更高(均p<0.05),皮质 periarterial 强化和基底节扩大血管周围间隙强化仅见于CSVD患者。结论认为无创动态增强MRI可可视化评估CSVD患者类淋巴-脑膜淋巴系统引流受损。
要点
- 高负荷CSVD患者皮质 periarterial 强化(11/20,55.00%)和基底节扩大血管周围间隙强化(16/20,80.00%)在对照组均未见。
- CSVD患者类淋巴和脑膜淋巴管的CR24h更低、∆SIR更高(均p<0.05)。
- 动态静脉增强3D-FLAIR和3D T1加权MRI可可视化评估类淋巴-脑膜淋巴系统引流功能。
核心结论
- 高负荷CSVD患者存在类淋巴-脑膜淋巴系统引流受损,可用静脉注射钆对比剂后的无创神经影像方法进行可视化评估。
研究设计与样本
- 观察性研究,纳入20例高负荷CSVD患者和15例对照(年龄50-80岁),行动态静脉注射对比剂前后多时间点3D脑容积T1加权成像和3D Cube T2-FLAIR成像,测量四个感兴趣区的SIR,采用方差分析校正高血压后比较组间差异。
关键影像表现/征象
- 皮质 periarterial 强化见于11例(55.00%)CSVD患者,对照组未见。
- 基底节扩大血管周围间隙强化见于16例(80.00%)CSVD患者,对照组未见。
- 所有CSVD患者和80.00%的对照者可见皮质 perivenous 强化。
- 所有参与者均可见窦旁强化。
诊断标准与关键数值
- 以24小时清除率(CR24h)和基线至24小时SIR变化(∆SIR)定义清除功能。
- CSVD患者类淋巴和脑膜淋巴管的CR24h低于对照、∆SIR高于对照(均p<0.05)。
临床应用与阅片要点
- 动态静脉增强3D-FLAIR和3D T1加权MRI上代表类淋巴-脑膜淋巴系统的信号强度变化可反映引流功能。
- 高负荷CSVD患者的类淋巴-脑膜淋巴系统引流受损可通过动态静脉增强MRI可视化评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the feasibility of using noninvasive neuroimaging methods in visualizing and evaluating the clearance of the glymphatic-meningeal lymphatic system (GMLS) in patients with arteriosclerotic cerebral small-vessel disease (CSVD) and controls.
METHODS: This observational study recruited patients with high-burden CSVD and controls (age 50-80 years). At multiple time points before and after intravenous administration of a contrast agent, three-dimensional (3D) brain volume T1-weighted imaging and 3D Cube T2-fluid attenuated inversion recovery imaging were performed to visualize and assess the clearance of the glymphatics and meningeal lymphatic vessels (mLVs). We measured the signal intensity ratio (SIR) of four regions of interest representing the glymphatics and mLVs at each time point. The clearance rate at 24 h (CR24h) and changes in the SIR from baseline to 24 h (∆SIR) were defined as the clearance function. The analysis of variance was used to evaluate the group differences after adjusting for hypertension.
RESULTS: A total of 20 CSVD patients and 15 controls were included. Cortical periarterial enhancement and the enhancement of enlarged perivascular spaces in the basal ganglia were respectively observed in 11 (55.00%) and 16 (80.00%) CSVD patients, but in none of controls. All CSVD patients and most of controls (80.00%) showed cortical perivenous enhancement. Para-sinus enhancement was observed in all participants. CSVD patients showed lower CR24h and higher ∆SIR of the glymphatics and mLVs (all p < 0.05).
CONCLUSION: The impaired drainage of the GMLS in patients with high-burden CSVD could be visually evaluated using noninvasive neuroimaging methods with intravenous gadolinium-based contrast-enhancement.
CLINICAL RELEVANCE STATEMENT: Dynamic intravenous contrast-enhanced MRI could visually evaluate the impaired drainage of the glymphatic-meningeal lymphatic system in patients with high-burden cerebral small-vessel disease and could help to explore a new therapeutic target.
KEY POINTS: • Signal intensity changes in regions representing the glymphatic-meningeal lymphatic system (GMLS) can reflect the drainage function based on contrast-enhanced 3D-FLAIR and 3D T1-weighted MRI. • Impaired drainage of the GMLS in patients with high-burden CSVD can be visually evaluated using dynamic intravenous contrast-enhanced MRI. • This direct, noninvasive technique could serve as a basis for further GMLS studies and could help to explore a new therapeutic target in CSVD patients.
引用
- Zhang, Tang, Xia, et al. Evaluation of glymphatic-meningeal lymphatic system with intravenous gadolinium-based contrast-enhancement in cerebral small-vessel disease. Eur Radiol. 2023. PMID: 37410111. doi:10.1007/s00330-023-09796-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。